Literatura
Kontakt Forum RSS
Ginekologija
Brojni znanstvenici istražuju uzroke, a drugi nastoje pronaći brzu i učinkovitu pomoć za liječenje ginekoloških oboljenja. Većina njih usmjerena je na tjelesne smetnje, dok je manje učinjeno na razjašnjenju psiholoških mehanizama povezanih s ovim tegobama.

Literatura

Vezano
Datum zadnje izmjene: 6. siječnja 2017.


Karck U. Endometriose. Gynäkologe 1997; 7:581-593

Valle RF. Endometriosis: current concepts and therapy. Int J Gyn Obstet 2002; 78: 107-119

Mounsey AL, Wilgus A, Slawson DC.
Diagnosis and Management of Endometriosis. Am Fam Physician 2006; 74: 594-600
Prentice A. Endometriosis. Regular review. BMJ 2001; 323: 93-5

Weinschenk S. Endometriose, Dymenorrhö, Sterilität und vegetatives Nervensystem. EHK 2004; 53: 523-32

Tonini G. Dysmenorrhoea, endometriosis and premenstrual syndrome. Minerva Pediatr 2002; 54 (6): 525-38

Farquhar C. Endometriosis. BMJ. 2007; 334(7587):249-53.

Viganò P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004; 18(2):177-200.

Cramer DW, Missmer SA.
The epidemiology of endometriosis. Ann N Y Acad Sci. 2002; 955:11-22.

Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997; 24(2):235-58.

Sangi-Haghpeykar H, Poindexter AN 3rd. Epidemiology of endometriosis among parous women. Obstet Gynecol. 1995;85(6):983-92.

Hemmings R, Rivard M, Olive DL et al. Evaluation of risk factors associated with endometriosis. fertil Steril 2004; 81 (6): 1513-21

Darrow SL, Vena JE, Batt RE et al. Menstrual cycle characteristics and the risk of endometriosis. Epidemiology. 1993; 4(2):135-42.

Arumugam K, Lim JM. Menstrual characteristics associated with endometriosis. Br J Obstet Gynaecol. 1997;104(8):948-50.

Candiani GB, Danesino V, Gastaldi A et al.
Reproductive and menstrual factors and risk of peritoneal and ovarian endometriosis. Fertil Steril. 1991; 56(2):230-4.

Cramer DW, Wilson E, Stillman RJ et al. The relation of endometriosis to menstrual characteristics, smoking, and exercise. JAMA. 1986; 255(14):1904-8.

Pan LY, Song HZ, Wu BZ. Reproductive activities as a risk factor of endometriosis. Zhonghua Fu Chan Ke Za Zhi. 1994; 29(3):150-3.

Pan L, Song H, Wu P. Personal characteristics as risk factors of endometriosis. Zhonghua Yi Xue Za Zhi. 1995; 75(1):34-6.

Darrow SL, Selman S, Batt RE et al. Sexual activity, contraception, and reproductive factors in predicting endometriosis. Am J Epidemiol. 1994;140(6):500-9.

Parazzini F, Ferraroni M, Fedele L et al. Pelvic endometriosis: reproductive and menstrual risk factors at different stages in Lombardy, northern Italy. J Epidemiol Community Health. 1995; 49(1):61-4.

Parazzini F, Ferraroni M, Bocciolone L et al. Contraceptive methods and risk of pelvic endometriosis. Contraception. 1994;49(1):47-55.

Vercellini P, Frontino G, Pietropaolo G et al. Deep endometriosis: definition, pathogenesis, and clinical management. J Am Assoc Gynecol Laparosc. 2004;11(2):153-61.

Sinaii N, Cleary SD, et al. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: A survey analysis. Hum Reprod. 2002 Oct;17(10):2715–24.

Lamb K, Nichols TR. Endometriosis: a comparison of associated disease histories. Am J Prev Med 1986; 2;6:324-9

Poppe K, Glinoer D, Tournaye H et al.
Thyroid autoimmunity and female infertility. Verh K Acad Geneeskd Belg. 2006; 68(5-6):357-77

Poppe K, Velkeniers B, Glinoer D.
Thyroid disease and female reproduction. Clin Endocrinol (Oxf). 2007; 66(3):309-21.

Vigano P, Somigliana E, Vignali M et al. Genetics of endometriosis: current status and prospects. Front Biosci. 2007 May 1;12:3247-55.

Di W, Guo SW. The search for genetic variants predisposing women to endometriosis. Curr Opin Obstet Gynecol. 2007; 19(4):395-401.

Govindan S, Ahmad SN, Vedicherla B et al. Association of progesterone receptor gene polymorphism (PROGINS) with endometriosis, uterine fibroids and breast cancer. Cancer Biomark. 2007;3(2):73-8.

Lattuada D, Somigliana E, Viganò P et al. Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS? Clin Endocrinol (Oxf). 20

Wieser F, Schneeberger C, Tong D et al. PROGINS receptor gene polymorphism is associated with endometriosis. Fertil Steril. 2002; 77(2):309-12.

Koninckx, PR. The physiopathology of endometriosis: Pollution and dioxin. Gynecol Obstet Invest. 1999;47(Suppl 1):47–50.

Mayani A, Barel S, et al. Dioxin concentrations in women with endometriosis. Hum Reprod. 1997 Feb;12(2):373–5.

Bhatt RV. Environmental influence on reproductive health. Int J Gynaecol Obstet 2000; 70;1:69-75

Neubert R, Jacob-Muller U, et al.
Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 2. In vitro effects of, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on lymphocytes of venous blood from man and a non-human primate (Callithrix jacchus). Arch Toxicol. 1991;65:213–9.

Rier SE, Martin DC, et al.
Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 1993 Nov;21(4):433–41.

Rier SE, Martin DC, et al.
Immunoresponsiveness in endometriosis: Implications of estrogenic toxicants. Environ Health Perspect. 1995 Oct;103(Suppl 7):151–6.

Rier SE, Turner WE, et al. Serum levels of TCDD and dioxin-like chemicals in Rhesus monkeys chronically exposed to dioxin: Correlation of increased serum PCB levels with endometriosis. Toxicol Sci. 2001 Jan;59(1):147–59.

Gazvani R, Templeton A.
New considerations for the pathogenesis of endometriosis. Int J Gynaecol Obstet. 2002;76(2):117-26.

Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update 1998; 4: 312-22

Leyendecker G, Junz G, Noe M et al.
Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod Update 1998; 4: 752-62

Leyendecker G, Herbertz M, Kunz G.
Neue Aspekte zur Pathogenese von Endometriose und Adenomyose. Frauenarzt 2002; 43 (3):297-306

Leyendecker G, Herbertz M, Kunz G. Mall G.
Endometriosis results from the dislocation of basal endometrium. Hum Reprod 2002; 17: 2725-36

Lebovic DI, Mueller MD, Taylor RN.
Immunobiology of endometriosis. Fertil Steril 2001; 75.1-10

Ulukus M, Arici A. Immunology of endometriosis. Minerva Ginecol. 2005 Jun;57(3):237–48.

Greb RR, Löbbecke K, Paletta JRJ, Kiesel L. Immunomodulation der Endometriose. Gynäkologe 2002; 35: 238-42

Rier SE, Martin DC, Bowman RE, Becker JL.
Immunoresponsiveness in Endometriosis: Implications of Estrogenic Toxicant. Environ Health Perspect 1995; 103 (Suppl 7): 151-6

Sidell N, Han SW, Parthasarathy S. Regulation and modulation of abnormal immune responses in endometriosis. Ann NY Acad Sci 2002; 955: 159-73

Seli E, Arixi A. Endometriosis: Interaction of Immune and Endocrine Systems. Sem Preprod Med 2003; Vol 21 (2): 135-44

Berkkanoglu M, Arici A. Immunology and endometriosis. Am J Reprod Immunol. 2003;50(1):48-59.

Gazvani R, Templeton A.
Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction. 2002; 123(2):217-26.

Ho HN, Wu MY, Yang YS.
Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol. 1997;38(6):400-12.

Chegini NC, Rong H, Bennett B, Stone K. Peritoneal Fluid Cytokine and Eicosanoid Levels and Their Relation to the Incidence of Periteonal Adhaesion. J Soc Gynecol Invest 1999; 6: 153-7

Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? Trends Mol Med 2003; 9 (5): 223-8

Mueller MD, Dreher E, Taylor RN. Auf der Spur eines Rätsels: Angiogenese und Endometriose. Geb Fra 2000; 12: 585-593

Barcz E, Kamiński P, Marianowski L.
Role of cytokines in pathogenesis of endometriosis. Med Sci Monit. 2000;6(5):1042-6.

Nishida M, Watanabe K, Sato N, Ichikawa Y. Malignant transformation of ovarian endometriosis. Gynecol Obstet Invest 2000; 50 Suppl 1: 18-25

McCluggage WG, Bryson C, Lamki H, Boyle DD. Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy. Int J Gynecol Pathol 2000; 19 (3): 276-9

Kobayashi H, Sumimoto K, Moniwa N et al. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer. 2007; 17(1):37-43.

Zanetta GM, Webb MJ, Keeney GL. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol 2000; 79 (1): 18-22

Dmowski WP, Lesniewicz R, et al.
Changing trends in the diagnosis of endometriosis: A comparative study of women with pelvic endometriosis presenting with chronic pelvic pain or infertility. Fertil Steril. 1997;67:238–43.

Brosens I, Puttemans P, et al.
Diagnosis of endometriosis: Pelvic endoscopy and imaging techniques. Best Pract Res Clin Obstet Gynaecol. 2004 Apr;18(2):285–303.

Bühler K. Endometriose. Medikamentöse Therapie. TW Gynäkologie 1997; 10:271-274

Hornung D, Licht P, Walleiner D.
Endometriose: Bewährte und innovative Therapiestrategien bei Schmerzen und Infertilität. Geburtsh Frauenheilk 2004; 64: 584-88

Rice VM. Conventional medical therapies for endometriosis. Ann NYAcad Sci 2002; 955: 343-52

Moghisi KS. Treatment of endometriosis with estrogen-progestin combination and progestogen alone. Clin Obstet Gynecol 1988; 31:823-8

Vercellini P, Cortesi I, Crosignani PG. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril 1997; 68: 393-401

Fedele L, Bianchi S, Zanconato G et al. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fert Steril 2001; 75 (3): 485-8

Jansen JT. Noncontraceptive applications of the levonorgestrel intrauterine system. Current Women’s Health Report 2002; 2:417-22

Schindler AE, Schweppe KW.
Endometriose - neue Therapiemöglichkeiten durch Buserelin. Walter de Gruyter Berlin New York 1989.

Kiesel L. Medikamentöse Therapie der Endometriose - Add back verringert Nebenwirkungen. Gyn Spectrum 1996: 2: 6-6

Cosson M, Querleu D, Donnez J, Madelenat P, Konincks P et al. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fert Ster 2002; 77 (4): 684-692

Regidor PA, Regidor M, Schmidt M, Ruwe B, Lübben G, Förtig P, Kienle E, Schindler AE.
Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis. Gyn Endocrinol 2002; 15 (3): 202-209

Busacca M, Somigliana E, Bianchi S, De Marinis S, Calica C, Candiani M, Vignali M. Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III-IV: a randomized controlled trial. Hum Reprod 2001; 16 (11): 2399-2402

Barbieri RL, Evans S, et al. Danazol in the treatment of endometriosis: Analysis of 100 cases with a 4-year follow-up. Fertil Steril. 1982 Jun;37(6):737–46.

Biberoglu KO, Behrman SJ.
Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gynecol 1981; 139: 645-54

Gleicher N. Immuninsuffizienz - ein potentieller Ansatz für die Behandlung der Endometriose. Br J Obstet Gynecol 1995; 102 (12):4-7

Kiesel L. Endometriose und Immunologie. TW Gynäkologie, 1996; 11:674-675

Strauss B. Psychosomatic aspects of endometriosis. Geburtshilfe Frauenheilkd. 1995; 55(2):M20-2.

Weinstein K. The emotional aspects of endometriosis: what the patient expects from her doctor. Clin Obstet Gynecol. 1988; 31(4):866-73

Denny E. Women's experience of endometriosis. J Adv Nurs. 2004; 46(6):641-8

Strauss B, Didzus A, Speidel H.
Eine Untersuchung zur Psychosomatik der Endometriose. Psychother Psychosom Med Psychol. 1992; 42 (7):242-52

Kennedy S. What is important to the patient with endometriosis? Br J Clin Pract Suppl 1991; 72;8-10; discussion 11-3

Martin DC, Ling F. W. Endometriosis and pain. Clin Obstet Gynecol 1999; 42;3:664-86

Low WY, Edelmann RJ, Sutton C. Short term psychological outcome of surgical intervention for endometriosis. Br J Obstet Gynaecol 1993; 100;2:191-2

Whitney ML. Importance of lay organizations for coping with endometriosis. J Reprod Med 1998; 43;3 Suppl:331-4

Wingfield MB, Wood C, Henderson LS, Wood RM. Treatment of endometriosis involving a self-help group positively affects patients' perception of care. J Psychosom Obstet Gynaecol 1997;18;4:255-8

Perper MM, Breitkopf L J, Breitstein et al. MAST scores, alcohol consumption, and gynecological symptoms in endometriosis patients. Alcohol Clin Exp Res 1993; 17;2:272-8

Low WY, Edelmann RJ, Sutton C. A psychological profile of endometriosis patients in comparison to patients with pelvic pain of other origins. J Psychosom Res. 1993; 37(2):111-6.

Lütje W, Brandeburg U. Psychosomatische Aspekte der Endometriose. Zentralbl Gynakol 2003; 125:281-5

Glase R, Rice J, Sheridan J et al. Stress-related immune suppression: health implications. Brain Behav Immun 1987; 1(1):7-20

Moyad MA, Pienta KJ. Mind-body effect: insulinlike growth factor-1; clinical depression; and breast, prostate and other cancer risk – an unmeasured and masked mediator of potential significance? Urology 2002; 59 (4 Suppl 1):4-8

Jarosch L, Grün A. Živi što jesi. Biblijski ženski likovi kao arhetipi. Kršćanska sadašnjost, Zagreb, 2006.

Northrup C. Žensko tijelo, ženska mudrost. Biovega Zagreb 2000.

Goldin BR, Adlercreutz H, Gorbach SL et al. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med; 1982; 307 (25): 1542-7

Parazzini F, Chiaffarino F, Surace M et al.
Selected food intake and risk of endometriosis. Hum Reprod 2004; 19 (8): 1755-9

Edmunds KM, Holloway AC, et al.
The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells. Reprod Nutr Dev. 2005 Nov-Dec;45(6):709–20.

Tsuchiya, Masaki [S]; Miura et al. Effect of Soy Isoflavones on Endometriosis: Interaction With Estrogen Receptor 2 Gene Polymorphism. Epidemiology. 18(3):402-408, May 2007.

Carper J. Hrana čudesni lijek, Leo Commerce Zagreb 2000.

Ackerson A. Eating the pain of endometriosis – Brief Article. Better Nutrition. Gale Group 2001.

Yano Y.
Effect of dietary supplementation with eicosapentaenoic acid on surgically induced endometriosis in the rabbit. Nippon Sanka Fujinka Gakkai Zasshi. 1992 Mar;44(3):282–8.

Covens AL, Christopher P, Casper RF. The effect of dietary supplementation with fish oil fatty acids on surgically induced endometriosis in the rabbit. Fertil Steril 1988; 49 (4): 698-703

Simopoulos AP. Omega 3 fatty acids in health in disease and growth and development. Am J Clin Nutr 1992; 54:438-63

Bayer W, Schmidt KH. Immunmodulatorische Wirkungen essentieller Fettsüren bei chronisch entzündlichen Erkrankungen. EHK 2003; 1:12-7

Calder PC.
N-3 polyunsaturated fatty acids, inflammation and immunity: Pouring oil on troubled waters or another fishy tale? Nutr Res. 2001;21:309–41.

Connor WE. n-3 Fatty acids from fish and fish oil: Panacea or nostrum? Am J Clin Nutr. 2001;74;415–6.

Gašparević-Ivanek V.
Upoznajmo masne kiseline - osnovu našeg zdravlja. Medix 1999; 23:95-96

Adam O.
Einfluss von n-3 Fettsüren auf den normalne und pathologischen Immunstatus des Menschen. Aktuel Enraehr Med 2004; 29: 178-82

Van Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril 2002; 77 (5): 861-70

Foster WG, Agarwal SK. Environmental contaminants and dietary factors in endometriosis. Ann NY Acad Sci 2002; 955: 213-29

Foyouzi N, Berkkanoglu M, et al. Effects of oxidants and antioxidants on proliferation of endometrial stromal cells. Fertil Steril. 2004 Oct;82 Suppl 3:1019–22.

FNB/IM. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press; 2000. Available at: http://www.nap.edu/books/0309069351/html/. Accessed May 10, 2005.

Mindell E.
Vitaminska biblija za 21. stoljeće. Mozaik knjiga Zagreb 2001.


Atkins R.
Vita-hranjiva Dr. Atkinsa. VBZ Zagreb, 1999.

Mindell E.
Tajni lijekovi, Mozaik knjiga Zagreb, 1999.

Null G. Enciklopedija za žene. Prirodnim liječenjem do zdravlja, Barka Zagreb 1999.

Fugh-Berman A, Kronenberg F. Complementary and alternative medicine (CAM) in reproductive-age women: a review of randomized controlled trials. Reprod Toxicol 2003; 17 (2): 137-52

Winehard J. Tinneberg HR.
Alternative Behandlungsmöglichkeiten der endometriosebedingten Beschwerden. Zantralbl Gynakol 2003; 125: 286-89

Volkmann PH. Kausale naturheilkundliche Endometriose-Therapie. EHK 2001; 4:195-202

Dog TL. Conventional and alternative treatments for endometriosis. Alternative Therapies 2001; 7:50-6

Theiss P, Kalođera Z. Ljekovito bilje za zdravu obitelj. Natur Produkt Zagreb 2004

Kuštrak D. Farmakognozija i fitofarmacija. Golden Marketing – Tehnička knjiga. Zagreb 2005

Agency for Healthcare Research and Quality. Milk thistle: Effects on liver disease and cirrhosis and clinical adverse effects: Summary. Evidence Report/Technology Assessment 2000; No. 21. Rockville. Available at: http://www.ahrq.gov/clinic/epcsums/milktsum.htm. Accessed May 10, 2005.

Flora K, Hahn M, et al. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol. 1998;93:139–43.

Literatura